Tuesday, April 25, 2006

DDRC Investigates HBOT Effect on QoL on Diabetic Neuropathy

The DDRC (Diving Diseases Research Center), always in the forefront studying hyperbarics, is investigating the long term effect of HBOT on the quality of life of patients with diabetic neuropathy. The condition can be devastating, causing loss of use as well as incapacitating pain. Read about this study (and others) at this site:

DDRC - investigation into the impact of Hyperbaric Oxygen Therapy (HBO2)
on Quality of Life (QoL) in patients with Diabetic Neuropathy